[1] |
Carsons S, Bhimji S. Sjogren Syndrome[J]. Nihon Naika Gakkai Zasshi the Journal of the Japanese Society of Internal Medicine, 2017, 88(10):1896-903.
|
[2] |
Borchers A T, Naguwa S M, Keen C L, et al. Immunopathogenesis of Sjogren's syndrome [J]. Clin Review Aller Immunol, 2003, 25(1): 89-104.
|
[3] |
Matrisian L M. Metalloproteinases and their inhibitors in matrix remodeling.[J]. Trends in Genetics Tig, 1990, 6(4):121-125.
|
[4] |
Ye S, Eriksson P, Hamsten A, et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.[J]. Journal of Biological Chemistry, 1996, 271(22):13055-13060.
|
[5] |
赵志玲. 基质金属蛋白酶及其抑制剂与类风湿性关节炎的研究进展[J]. 解放军药学学报, 2005, 21(1):59-61.
|
[6] |
张军, 俞创奇, 王丽珍. 基质金属蛋白酶在舍格伦综合征患者唇腺组织中的表达及意义[J]. 中国口腔颌面外科杂志, 2006, 4(6):430-433.
|
[7] |
俞洁, 章功杰, 陈松军,等. 糖尿病患者唾液流率与口干相关性研究[J]. 口腔医学研究, 2016, 32(2):177-180.
|
[8] |
Novakovic N, Todorovic T, Rakic M, et al. Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome.[J]. Journal of Periodontal Research, 2014, 49(1):129-136.
|
[9] |
赵云阁, 欧尔比特?安尼瓦尔, 祝诚. 细胞外基质与基质金属蛋白酶[J]. 生物化学与生物物理进展, 1999, 26(3):223-227.
|
[10] |
Kadoya Y, Yamashina S. Salivary gland morphogenesis and basement membranes[J]. Anatomical Science International, 2015, 80(2):71-79.
|
[11] |
王松灵, 邹兆菊, 孙开华,等. 舍格伦综合征腮腺的超微病理观察[J]. 中华口腔医学杂志, 1994(5):283-284.
|
[12] |
Sisto M, D'Amore M D, Scagliusi P, et al. Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome.[J]. International Immunology, 2009, 21(3):303-311.
|
[13] |
Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases[J]. Amino Acids, 2011, 41(2):271-290.
|
[14] |
Pérez P, Kwon YJ, Alliende C, et al. Increased acinar damage of salivary glands of patients with Sjogren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteina [J]. Arthritis Rheum, 2014, 52(9): 2751-2760.
|
[15] |
Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, et al.Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome [J]. Arthritis Rheum, 2000, 43(12): 2807-2817.
|
[16] |
Molina C, Alliende C, Aguilera S, et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sj?gren’s syndrome: association with mononuclear cell infiltration[J]. Annals of the Rheumatic Diseases, 2006, 65(2):178-183.
|
[17] |
Condò R, Costacurta M, Docimo R. The anti-transglutaminase auto-antibodies in children's saliva with a suspect coeliac disease: clinical study[J]. Oral Implantol (Rome) , 2013,6(2):48-54.
|
[18] |
Hu S, Gao K, Pollard R, et al. Preclinical validation of salivary biomarkers for primary Sjogren's syndrome [J]. Arthritis Care & Research, 2010, 62(11):1633-1638.
|
[19] |
Giusti L, Baldini C, Ciregia F, et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?[J]. Proteomics Clin Appl, 2010, 4(3):315-324.
|
[20] |
Streckfus C F, Bigler L R. Saliva as a diagnostic fluid[J]. Oral Diseases, 2011, 55(1):159-178.
|